Secure and efficient data transfer in AODV routing protocol using RSA encryption
i-manager's Journal on Digital Forensics & Cyber Security · 2023
DOI: 10.26634/jdf.1.1.19389 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift i-manager's Journal on Digital Forensics & Cyber Security, 2023. Verfasst von Ngazi Mangazi Chatheka und 1 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Mobile Ad-Hoc Networks (MANETs) are recognised as a key emerging technology for use whenever cellular communications are either infeasible, inefficient, or cost-ineffective. MANETS are composed of nodes that are arranged in a self-organizing manner, without a central device like a switch or router. The nodes communicate with each other over wireless links and cooperate in a distributed fashion. Smartphones are the most ideal network nodes in many scenarios where traditional networks are unavailable, but building a secure network with them is not easy. This paper extensively uses the existing possibilities to build a secure MANET. The designed MANET has been built on an NS3 simulator, with the base protocol being Ad-hoc On-demand Distance Vector (AODV) and message encryption is done by using RSA Algorithm. The Secure AODV protocol extension is implemented using the RSA extension.
Zitieren
APA
Chatheka, N. M., & Glorindal, S. (2023). Secure and efficient data transfer in AODV routing protocol using RSA encryption. i-manager's Journal on Digital Forensics & Cyber Security. https://doi.org/10.26634/jdf.1.1.19389
Vancouver
Chatheka NM, Glorindal S. Secure and efficient data transfer in AODV routing protocol using RSA encryption. i-manager's Journal on Digital Forensics & Cyber Security. 2023. doi:10.26634/jdf.1.1.19389
BibTeX
@article{Chatheka2023,
author = {Chatheka, Ngazi Mangazi and Glorindal, Selvam},
title = {Secure and efficient data transfer in AODV routing protocol using RSA encryption},
journal = {i-manager's Journal on Digital Forensics & Cyber Security},
year = {2023},
doi = {10.26634/jdf.1.1.19389}
}
EUVIMED